Cargando…

Blood purification with a cytokine adsorber for the elimination of myoglobin in critically ill patients with severe rhabdomyolysis

BACKGROUND: Rhabdomyolysis is frequently occurring in critically ill patients, resulting in a high risk of acute kidney injury (AKI) and potentially permanent kidney damage due to increased myoglobin levels. The extracorporeal elimination of myoglobin might be an approach to prevent AKI, but its mol...

Descripción completa

Detalles Bibliográficos
Autores principales:	Scharf, Christina, Liebchen, Uwe, Paal, Michael, Irlbeck, Michael, Zoller, Michael, Schroeder, Ines
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7844984/ https://www.ncbi.nlm.nih.gov/pubmed/33509234 http://dx.doi.org/10.1186/s13054-021-03468-x

Ejemplares similares

Successful elimination of bilirubin in critically ill patients with acute liver dysfunction using a cytokine adsorber and albumin dialysis: a pilot study
por: Scharf, Christina, et al.
Publicado: (2021)

Can the cytokine adsorber CytoSorb(®) help to mitigate cytokine storm and reduce mortality in critically ill patients? A propensity score matching analysis
por: Scharf, Christina, et al.
Publicado: (2021)

Does the cytokine adsorber CytoSorb(®) reduce vancomycin exposure in critically ill patients with sepsis or septic shock? a prospective observational study
por: Scharf, Christina, et al.
Publicado: (2022)

The cytokine adsorber Cytosorb® does not reduce ammonia concentrations in critically ill patients with liver failure
por: Liebchen, Uwe, et al.
Publicado: (2023)

The effect of cytosorb® application on kidney recovery in critically ill patients with severe rhabdomyolysis: a propensity score matching analysis
por: Gräfe, Caroline, et al.
Publicado: (2023)

The higher the better? Defining the optimal beta-lactam target for critically ill patients to reach infection resolution and improve outcome
por: Scharf, Christina, et al.
Publicado: (2020)

Therapeutic Drug Monitoring of Meropenem and Piperacillin in Critical Illness—Experience and Recommendations from One Year in Routine Clinical Practice
por: Scharf, Christina, et al.
Publicado: (2020)

No clinically relevant removal of meropenem by cytokine adsorber CytoSorb(®) in critically ill patients with sepsis or septic shock
por: Liebchen, Uwe, et al.
Publicado: (2021)

CytoSorb® Hemoadsorption as a Promising Tool to Handle COVID-19-Induced Cytokine Storm
por: Acevedo, Alice-Christin, et al.
Publicado: (2021)

Systematic Evaluation of Voriconazole Pharmacokinetic Models without Pharmacogenetic Information for Bayesian Forecasting in Critically Ill Patients
por: Kallee, Simon, et al.
Publicado: (2022)

Digestive enzymes of fungal origin as a relevant cause of false positive Aspergillus antigen testing in intensive care unit patients
por: Schroeder, Ines, et al.
Publicado: (2020)

The correlation between creatine kinase and myoglobin in critical ill patients with rhabdomyolysis
por: Mikkelsen, TS, et al.
Publicado: (2004)

Evaluation of the MeroRisk Calculator, A User-Friendly Tool to Predict the Risk of Meropenem Target Non-Attainment in Critically Ill Patients
por: Liebchen, Uwe, et al.
Publicado: (2021)

Optimal loading dose of meropenem before continuous infusion in critically ill patients: a simulation study
por: Liebchen, Uwe, et al.
Publicado: (2021)

Extracorporeal therapies in acute rhabdomyolysis and myoglobin clearance
por: Ronco, Claudio
Publicado: (2005)

Was ist neu … in der Behandlung von invasiven Mykosen. COVID-19-assoziierte pulmonale Aspergillose
por: Scharf, Christina, et al.
Publicado: (2021)

Nichtinvasive respiratorische Unterstützung und invasive Beatmung bei COVID‑19: Wo stehen wir heute?
por: Schroeder, Ines, et al.
Publicado: (2022)

Extracorporeal Removal of Myoglobin in Patients with Rhabdomyolysis and Acute Kidney Injury: Comparison of High and Medium Cut-Off Membrane and an Adsorber Cartridge
por: Jerman, Alexander, et al.
Publicado: (2022)

The Role of Non-Enzymatic Degradation of Meropenem—Insights from the Bottle to the Body
por: Liebchen, Uwe, et al.
Publicado: (2021)

Therapeutic drug monitoring-guided high dose meropenem therapy of a multidrug resistant Acinetobacter baumannii - A case report
por: Liebchen, U., et al.
Publicado: (2019)

Intermittent hemodiafiltration rapidly decreases serum myoglobin levels in rhabdomyolysis
por: Pettilä , V, et al.
Publicado: (1997)

Systematic Evaluation of Pharmacokinetic Models for Model-Informed Precision Dosing of Meropenem in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy
por: Schatz, Lea Marie, et al.
Publicado: (2023)

Rhabdomyolysis in Critically Ill Surgical Patients
por: Kuzmanovska, Biljana, et al.
Publicado: (2016)

Comparison of Cerebrospinal Fluid Collection Through the Proximal and Distal Port Below the Overflow System from an External Ventricular Drain
por: Kinast, Christina Barbara, et al.
Publicado: (2022)

Etiological Spectrum and Histopathological Diagnosis of Rhabdomyolysis Associated Myoglobin Cast Nephropathy in South India
por: Jansi Prema, K. S., et al.
Publicado: (2021)

Simultaneous quantification of seven repurposed COVID-19 drugs remdesivir (plus metabolite GS-441524), chloroquine, hydroxychloroquine, lopinavir, ritonavir, favipiravir and azithromycin by a two-dimensional isotope dilution LC–MS/MS method in human serum
por: Habler, Katharina, et al.
Publicado: (2021)

Extracorporeal adsorption of protective and toxic bile acids and bilirubin in patients with cholestatic liver dysfunction: a prospective study
por: Greimel, Antonia, et al.
Publicado: (2023)

Predictive Value of Serum Myoglobin and Creatine Phosphokinase for Development of Acute Kidney Injury in Traumatic Rhabdomyolysis
por: Raju, Nithin Abraham, et al.
Publicado: (2017)

Myoglobin clearance by super high-flux hemofiltration in a case of severe rhabdomyolysis: a case report
por: Naka, Toshio, et al.
Publicado: (2005)

Charakteristika und Outcome von 70 beatmeten COVID-19-Patienten: Bilanz nach der ersten Welle an einem universitären Zentrum
por: Schroeder, Ines, et al.
Publicado: (2020)

A Novel Rabbit Anti-Myoglobin Monoclonal Antibody’s Potential Application in Rhabdomyolysis Associated Acute Kidney Injury
por: Wang, Xinyue, et al.
Publicado: (2023)

Acute Kidney Injury Following Rhabdomyolysis in Critically Ill Patients
por: Saverymuthu, Alvin, et al.
Publicado: (2021)

Towards model-informed precision dosing of piperacillin: multicenter systematic external evaluation of pharmacokinetic models in critically ill adults with a focus on Bayesian forecasting
por: Greppmair, Sebastian, et al.
Publicado: (2023)

An Autopsy Case of Idiopathic Rhabdomyolysis in 1979: Immunoperoxidase Detection of Myoglobin Casts in Formalin-Fixed, Paraffin-Embedded Sections of the Kidney
por: Tsutsumi, Yutaka
Publicado: (2021)

Rhabdomyolysis in Critically Ill Patients With COVID-19: A Retrospective Study
por: Nashwan, Abdulqadir J, et al.
Publicado: (2023)

Dialyzer clearance of myoglobin with middle molecule filter and low blood flow CVVHD in patients with rhabdomyolysis-associated acute kidney injury
por: Leppanen, I, et al.
Publicado: (2013)

Acute kidney injury due to myoglobin cast nephropathy in the setting of coronavirus disease 2019-mediated rhabdomyolysis: a case report
por: Tuan, Jessica J., et al.
Publicado: (2022)

Synthesizing a Hybrid Nanocomposite as an Affinity Adsorbent through Surface-Initiated Atom Transfer Radical Polymerization Catalyzed by Myoglobin
por: Hajizadeh, Solmaz, et al.
Publicado: (2021)

Purification of influenza virus‐like particles using sulfated cellulose membrane adsorbers
por: B Carvalho, Sofia, et al.
Publicado: (2017)

Duodenal tropism of SARS-CoV-2 and clinical findings in critically ill COVID-19 patients
por: Neuberger, Michael, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ifhfjug48fdlfqsjv2u0vuahgg